Boston Scientific Corp
Change company Symbol lookup
Select an option...
BSX Boston Scientific Corp
NKE Nike Inc
AAPL Apple Inc
VXRT Vaxart Inc
VIGI Vanguard International Dividend Appreciation Index Fund ETF Shares
VIG Vanguard Dividend Appreciation Index Fund ETF Shares
VIAC ViacomCBS Inc
VGK Vanguard FTSE Europe Index Fund ETF Shares
VGI Virtus Global Multi-Sector Income Fund
VDE Vanguard Energy Index Fund ETF Shares
Go

Health Care : Health Care Equipment & Supplies | Large Cap Growth
Company profile

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology. It operates in three segments: Cardiovascular, Rhythm Management and MedSurg. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Rhythm Management consists of Cardiac Rhythm Management and Electrophysiology businesses. MedSurg consists of Endoscopy, Urology and Pelvic Health, and Neuromodulation businesses. Its Interventional Cardiology product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters and embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.

Closing Price
$39.31
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
7,692,619
0

Display:

Providers:

UpdateCancel
6 providers
August 03, 2020
Electrophysiology Devices Market to Hit USD 9.71 Bn by 2027; Growing Demand for Efficient Diagnostics for Heart Conditions to Favor Market Expansion: Fortune Business Insights(TM)

The global electrophysiology devices market size is projected to reach USD 9.71 billion by 2027, exhibiting a CAGR of 10.8% during the forecast period. The COVID-19 pandemic is expected to stoke the adoption of these devices owing to its close...(Globe Newswire)

July 30, 2020
BioTelemetry, Inc. Announces Sales Agent Agreement with Boston Scientific Corporation

BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today announced a sales agent agreement with Boston Scientific...(Globe Newswire)

July 29, 2020
Boston Scientific Announces Results For Second Quarter 2020

Boston Scientific Corporation (NYSE: BSX) generated sales of $2.003 billion during the second quarter of 2020. This represents a decline of (23.9) percent on a reported basis, (23.1) percent on an operational1 basis and (28.7) percent on an organic2...(PR Newswire)

July 28, 2020
Kidney Stone Management Market Worth USD 2.21 Billion by 2027; Government-supported Reimbursement Policies to Help Gain Traction: Fortune Business Insights(TM)

The global kidney stone management market size is expected to rise prominently on account of the increasing cases of kidney stone among people worldwide. This is further attributed to the formation of crystal-like substances such as uric acid...(Globe Newswire)

July 21, 2020
Boston Scientific Receives FDA Approval for Next-Generation WATCHMAN FLX(TM) Left Atrial Appendage Closure Device

Boston Scientific Corporation (NYSE: BSX) announced it has received U.S. Food and Drug Administration (FDA) approval for the WATCHMAN FLX(TM) Left Atrial Appendage Closure (LAAC) Device. Experience the interactive Multichannel News Release here...(PR Newswire)

July 16, 2020
Bronchoscopy Global Market Report 2020-30: Covid 19 Implications and Growth

Reportlinker.com announces the release of the report "Bronchoscopy Global Market Report 2020-30: Covid 19 Implications and Growth" - https://www.reportlinker.com/p05932643/?utm_source=GNW Hoffmann-La Roche Ltd. (Globe Newswire)

July 15, 2020
Paul LaViolette Appointed To Edwards Lifesciences Board Of Directors

Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that Paul A. LaViolette has been appointed to its board of directors. LaViolette...(PR Newswire)

July 01, 2020
Michael Enxing joins PainTEQ Board of Directors

PainTEQ, a leading medical device innovator, announced the appointment of Michael Enxing, Chief Commercial Officer of Boston Scientific Corporation, Neuromodulation Division. PainTEQ is the creator of LinQ (pronounced "link"), a minimally invasive...(PR Newswire)

June 30, 2020
Boston Scientific Announces Conference Call Discussing Second Quarter 2020 Financial Results

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ended June 30, 2020 on Wednesday, July 29, 2020 at 8:00 a.m. EDT. The call will be hosted by Mike...(PR Newswire)

A Growing List of Professional Sports Organizations, Businesses, Schools and Others Are Using VenueScreen's Thermal Imaging Cameras and CDC- and HIPAA-Based Protocols

As states reopen work and public places, a Twin Cities-based company is helping to ensure healthy environments with its sophisticated thermal-imaging systems and HIPAA- and CDC-protocols guided by Boston Scientific. VenueScreen * recently passed a...(BusinessWire)

June 29, 2020
Boston Scientific Receives FDA 510(k) Clearance for the LUX-Dx(TM) Insertable Cardiac Monitor System

Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the LUX-Dx(TM) Insertable Cardiac Monitor (ICM) System, a new, long-term diagnostic device implanted in patients to detect arrhythmias associated...(PR Newswire)

June 19, 2020
Deep Brain Stimulation Devices Market to Exhibit a CAGR of 11.6% by 2026; Rising Geriatric Population to Enable Expansion, states Fortune Business Insights(TM)

The global deep brain stimulation devices market size is expected to reach USD 1,676.8 million by 2026, exhibiting a CAGR of 11.6% during the forecast period. The growing prevalence of neurological disorders can be a crucial factor augmenting the...(Globe Newswire)

June 09, 2020
Sophisticated Medical Devices Allow for Improved Patient Monitoring

Medical devices range from simple tongue depressors and bedpans to complex programmable pacemakers and closed loop artificial pancreas systems. In addition, in vitro diagnostic (IVD) products, such as reagents, test kits, and blood glucose meters as...(PR Newswire)

June 08, 2020
Boston Scientific Receives Medicare Transitional Pass-Through Payment for the EXALT(TM) Model D Single-Use Duodenoscope

Boston Scientific (NYSE: BSX) today announced that the Centers for Medicare & Medicaid Services (CMS) has approved its application for a transitional pass-through (TPT) payment category to describe single-use endoscopes, including the EXALT(TM)...(PR Newswire)

Electrophysiology Devices Market to Reach USD 10.51 Billion by 2026; Increasing Number of Product Launches to Aid Growth, says Fortune Business Insights

The global electrophysiology devices market size is projected to reach USD 10.51 billion by 2026. According to a report published by Fortune Business Insights, titled "Electrophysiology Devices Market Size, Share & Industry Analysis, By Type...(Globe Newswire)

Human Insulin Market to Reach USD 27.71 Billion by 2026, Technological Advancements in Insulin Pens to Spur Growth: Fortune Business Insights

The global human insulin market size is anticipated to reach USD 27.71 billion by 2026. International Diabetes Federation (IDF) reported that around 425 million people across the world suffer from diabetes. This shows that the rising prevalence of...(Globe Newswire)

June 03, 2020
Defibrillator Market Size to Reach US$ 14,806.4 Mn by 2026, Demand for Implantable Cardioverter Defibrillator to Boost the Market, says Fortune Business Insights

The global defibrillator market is likely to expand considerably in the coming years due to the increasing incidence of out of hospital cardiac arrests. According to a report published by Fortune Business Insights, titled "Defibrillator: Global...(Globe Newswire)

Cardiac Rhythm Management Devices Market to Register 4.4% CAGR, Boston Scientific Corporation and Medtronic Covers Majority of the Share: Fortune Business Insights

Technological advancements in cardiac rhythm devices are driving the global cardiac rhythm management devices market. Fortune Business Insights in a report, titled "Cardiac Rhythm Management Devices Market: Global Market Analysis, Insights and...(Globe Newswire)

Pain Management Devices Market to Witness 9.1% CAGR; Boston Scientific's 'Spectra WaveWriter' Launch to Enable Growth, says Fortune Business Insights

The global pain management devices market will benefit from increasing regulatory approvals for neuromodulation devices in recent years. According to a report published by Fortune Business Insights, titled "Pain Management Devices: Global Market...(Globe Newswire)

June 02, 2020
mHealth Apps Market to Gain Exponentially Exhibiting 29.1% CAGR by 2026; Increasing Demand for Smartphones to Stimulate Demand: Fortune Business Insights(TM)

The global mHealth apps market size is expected to gain momentum by reaching USD 57.57 billion by 2026, while exhibiting astonishing CAGR of 29.1% between 2019 and 2026. Fortune Business Insights, publish this information in its latest report...(Globe Newswire)

Next >

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.